{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:20:07Z","timestamp":1761862807487},"reference-count":34,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Praziquantel (PZQ) is the drug of choice for schistosomiasis and probably is the only highly effective drug currently available for treating schistosomiasis-infected individuals. The mode of action of PZQ involves increasing the calcium uptake of the parasite, resulting in tegumental damage and death of the parasite. Despite its remarkable function, the target of PZQ has not been identified yet. To begin to understand where PZQ acts, in this study we expressed the cDNA library of\n            <jats:italic>Schistosoma mansoni<\/jats:italic>\n            on the surface of T7 bacteriophages and screened this library with labeled PZQ. This procedure identified a clone that strongly bound to PZQ. Subsequent DNA analysis of inserts showed that the clone coded for regulatory myosin light chain protein. The gene was then cloned, and recombinant\n            <jats:italic>S. mansoni<\/jats:italic>\n            myosin light chain (SmMLC) was expressed. Immunoblot analysis using antibodies raised to recombinant SmMLC (rSmMLC) showed that SmMLC is abundantly expressed in schistosomula and adult stages compared to the amount in cercarial stages. In vitro analyses also confirmed that PZQ strongly binds to rSmMLC. Further, peptide mapping studies showed that PZQ binds to amino acids 46 to 76 of SmMLC. Immunoprecipitation analysis confirmed that SmMLC is phosphorylated in vivo upon exposure to PZQ. Interestingly, significant levels of anti-SmMLC antibodies were present in vaccinated mice compared to the amount in infected mice, suggesting that SmMLC may be a potential target for protective immunity in schistosomiasis. These findings suggest that PZQ affects SmMLC function, and this may have a role in PZQ action.\n          <\/jats:p>","DOI":"10.1128\/aac.01222-08","type":"journal-article","created":{"date-parts":[[2008,12,23]],"date-time":"2008-12-23T02:09:06Z","timestamp":1229998146000},"page":"1054-1060","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":56,"title":["Praziquantel Affects the Regulatory Myosin Light Chain of\n            <i>Schistosoma mansoni<\/i>"],"prefix":"10.1128","volume":"53","author":[{"given":"Munirathinam","family":"Gnanasekar","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, University of Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok M.","family":"Salunkhe","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific, Rockford, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Krishna","family":"Mallia","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific, Rockford, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Xun","family":"He","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, University of Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramaswamy","family":"Kalyanasundaram","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, University of Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0163-7258(85)90020-8","volume":"29","year":"1985","unstructured":"Andrews, P. 1985. Praziquantel: mechanisms of anti-schistosomal activity. Pharmacol. Ther.29:129-156.","journal-title":"Pharmacol. Ther."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1017\/S0031182007002600","volume":"134","year":"2007","unstructured":"Angelucci, F., A. Basso, A. Bellelli, M. Brunori, L. Pica Mattoccia, and C. Valle. 2007. The anti-schistosomal drug praziquantel is an adenosine antagonist. Parasitology134:1215-1221.","journal-title":"Parasitology"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-6851(81)90019-0","volume":"4","year":"1981","unstructured":"Atkinson, K. H., and B. G. Atkinson. 1981. Protein synthesis in vivo by Schistosoma mansoni cercariae. Mol. Biochem. Parasitol.4:205-216.","journal-title":"Mol. Biochem. Parasitol."},{"key":"e_1_3_2_5_2","first-page":"715","volume":"21","year":"1991","unstructured":"Awadalla, H. N., M. Z. el Azzouni, A. I. Khalil, and S. T. el Mansoury. 1991. Scanning electron microscopy of normal and praziquantel treated S. haematobium worms (Egyptian strain). J. Egypt Soc. Parasitol.21:715-722.","journal-title":"J. Egypt Soc. Parasitol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0031182000060807","volume":"104","year":"1992","unstructured":"Blair, K. L., J. L. Bennett, and R. A. Pax. 1992. Praziquantel: physiological evidence for its site(s) of action in magnesium-paralysed Schistosoma mansoni. Parasitology104:59-66.","journal-title":"Parasitology"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1432-1033.1994.tb20025.x","volume":"226","year":"1994","unstructured":"Crameri, R., R. Jaussi, G. Menz, and K. Blaser. 1994. Display of expression products of cDNA libraries on phage surfaces. A versatile screening system for selective isolation of genes by specific gene-product\/ligand interaction. Eur. J. Biochem.226:53-58.","journal-title":"Eur. J. Biochem."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(02)90405-0"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/14787210.4.2.199","volume":"4","year":"2006","unstructured":"Doenhoff, M. J., and L. Pica-Mattoccia. 2006. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Exp. Rev. Anti-Infect. Ther.4:199-210.","journal-title":"Exp. Rev. Anti-Infect. Ther."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/09674845.2007.11732782","volume":"64","year":"2007","unstructured":"El-Bassiouni, E. A., M. H. Helmy, E. I. Saad, M. A. El-Nabi Kamel, E. Abdel-Meguid, and H. S. Hussein. 2007. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether. Br. J. Biomed. Sci.64:168-174.","journal-title":"Br. J. Biomed. Sci."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(80)90366-0","volume":"64","year":"1980","unstructured":"Fetterer, R. H., R. A. Pax, and J. L. Bennett. 1980. Praziquantel, potassium and 2,4-dinitrophenol: analysis of their action on the musculature of Schistosoma mansoni. Eur. J. Pharmacol.64:31-38.","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.8.4707-4715.2004"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2004.09.004","volume":"35","year":"2005","unstructured":"Greenberg, R. M. 2005. Are Ca2+ channels targets of praziquantel action? Int. J. Parasitol.35:1-9.","journal-title":"Int. J. Parasitol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/expr.1995.1030","volume":"80","year":"1995","unstructured":"Hall, T. M., G. T. Joseph, and M. Strand. 1995. Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen. Exp. Parasitol.80:242-249.","journal-title":"Exp. Parasitol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4269\/ajtmh.1991.45.360","volume":"45","year":"1991","unstructured":"Homeida, M. A., I. el Tom, T. Nash, and J. L. Bennett. 1991. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. Am. J. Trop. Med. Hyg.45:360-365.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjhyper.2006.05.024","volume":"20","year":"2007","unstructured":"Hu, W. Y., Y. J. Han, L. Z. Gu, M. Piano, and P. de Lanerolle. 2007. Involvement of ras-regulated Myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats. Am. J. Hypertens.20:53-61.","journal-title":"Am. J. Hypertens."},{"key":"e_1_3_2_17_2","first-page":"46","volume":"201","year":"1999","unstructured":"Hypolite, J. A., M. E. DiSanto, A. J. Wein, and S. Chacko. 1999. Myosin light chain phosphorylation at resting level and the composition of myosin isoforms in the bladder body and urethra. Scand. J. Urol. Nephrol. Suppl.201:46-50.","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"key":"e_1_3_2_18_2","first-page":"274","volume":"34","year":"2003","unstructured":"Liang, Y. S., J. R. Dai, Y. C. Zhu, G. C. Coles, and M. J. Doenhoff. 2003. Genetic analysis of praziquantel resistance in Schistosoma mansoni. Southeast Asian J. Trop. Med. Public Health34:274-280.","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0020-7519(00)00108-9","volume":"31","year":"2001","unstructured":"Mitsui, Y., and K. Arizono. 2001. A direct competitive enzyme-linked immunosorbent assay (ELISA) for determination of praziquantel concentration in serum. Int. J. Parasitol.31:87-91.","journal-title":"Int. J. Parasitol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4269\/ajtmh.1985.34.314","volume":"34","year":"1985","unstructured":"Morcos, S. H., M. T. Khayyal, M. M. Mansour, S. Saleh, E. A. Ishak, N. I. Girgis, and M. A. Dunn. 1985. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Am. J. Trop. Med. Hyg.34:314-321.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_21_2","first-page":"313","volume":"35","year":"2005","unstructured":"Omar, A., S. Elmesallamy Gel, and S. Eassa. 2005. Comparative study of the hepatotoxic, genotoxic and carcinogenic effects of praziquantel distocide & the natural myrrh extract Mirazid on adult male albino rats. J. Egypt Soc. Parasitol.35:313-329.","journal-title":"J. Egypt Soc. Parasitol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1152\/jappl.2001.91.1.497","volume":"91","year":"2001","unstructured":"Pfitzer, G. 2001. Invited review: regulation of myosin phosphorylation in smooth muscle. J. Appl. Physiol.91:497-503.","journal-title":"J. Appl. Physiol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.exppara.2008.03.012","volume":"119","year":"2008","unstructured":"Pica-Mattoccia, L., T. Orsini, A. Basso, A. Festucci, P. Liberti, A. Guidi, A. L. Marcatto-Maggi, S. Nobre-Santana, A. R. Troiani, D. Cioli, and C. Valle. 2008. Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death. Exp. Parasitol.119:332-335.","journal-title":"Exp. Parasitol."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204114200"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0955-0674(92)90057-J"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.12.018"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijantimicag.2007.05.004","volume":"30","year":"2007","unstructured":"Troiani, A. R., L. Pica-Mattoccia, C. Valle, D. Cioli, G. Mignogna, F. Ronketti, and M. Todd. 2007. Is actin the praziquantel receptor? Int. J. Antimicrob. Agents30:280-281.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00121066","volume":"15","year":"1994","unstructured":"Trybus, K. M. 1994. Role of myosin light chains. J. Muscle Res. Cell Motil.15:587-594.","journal-title":"J. Muscle Res. Cell Motil."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.trstmh.2004.06.009","volume":"99","year":"2005","unstructured":"Vennervald, B. J., M. Booth, A. E. Butterworth, H. C. Kariuki, H. Kadzo, E. Ireri, C. Amaganga, G. Kimani, L. Kenty, J. Mwatha, J. H. Ouma, and D. W. Dunne. 2005. Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg.99:150-160.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"e_1_3_2_30_2","first-page":"542","volume":"31","year":"1981","unstructured":"Webbe, G., C. James, G. S. Nelson, and R. F. Sturrock. 1981. The effect of praziquantel on Schistosoma haematobium, S. japonicum and S. mansoni in primates. Arzneimittelforschung31:542-544.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0166-6851(93)90100-C","volume":"58","year":"1993","unstructured":"Weston, D., J. Schmitz, W. M. Kemp, and W. Kunz. 1993. Cloning and sequencing of a complete myosin heavy chain cDNA from Schistosoma mansoni. Mol. Biochem. Parasitol.58:161-164.","journal-title":"Mol. Biochem. Parasitol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2307\/3283560","volume":"78","year":"1992","unstructured":"Wiest, P. M., Y. Li, G. R. Olds, and W. D. Bowen. 1992. Inhibition of phosphoinositide turnover by praziquantel in Schistosoma mansoni. J. Parasitol.78:753-755.","journal-title":"J. Parasitol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0031182000007137","volume":"122","year":"2001","unstructured":"William, S., S. Botros, M. Ismail, A. Farghally, T. A. Day, and J. L. Bennett. 2001. Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology122:63-66.","journal-title":"Parasitology"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1139\/y94-200","volume":"72","year":"1994","unstructured":"Zhang, Y., S. Moreland, and R. S. Moreland. 1994. Regulation of vascular smooth muscle contraction: myosin light chain phosphorylation dependent and independent pathways. Can. J. Physiol. Pharmacol.72:1386-1391.","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-3024.1998.00189.x","volume":"20","year":"1998","unstructured":"Zhang, Y., M. G. Taylor, and Q. D. Bickle. 1998. Schistosoma japonicum myosin: cloning, expression and vaccination studies with the homologue of the S. mansoni myosin fragment IrV-5. Parasite Immunol.20:583-594.","journal-title":"Parasite Immunol."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01222-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01222-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:55:47Z","timestamp":1645473347000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01222-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1128\/AAC.01222-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.01222-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"2008-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-12-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}